NCT06602973

Brief Summary

This pilot study is a first step in looking at the relationship between exercise and appetite in women with loss of control eating.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 30, 2024

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

September 12, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 21, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 21, 2026

Completed
Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

1.6 years

First QC Date

September 12, 2024

Last Update Submit

April 24, 2026

Conditions

Keywords

exerciseeating disorders

Outcome Measures

Primary Outcomes (1)

  • Relative Energy Intake

    Relative energy intake for 24 hours will be calculated as absolute energy intake from the breakfast (if consumed), lunch, food reward value task, and take home cooler minus energy expenditure during exercise (or comparable time period during rest).

    Food intake from 8 am to 8 am; Energy expenditure from approximately 9 am to 9:05 am and 9:25 to 9:30 am, coinciding with study condition (rest or exercise)

Secondary Outcomes (4)

  • Lactate

    30 minutes, pre-post exercise (or rest)

  • Acylated ghrelin

    Immediately prior to lunch

  • Self-reported binge eating

    24 and 48 hours after exercise/rest study visit

  • Food reward value

    Approximately 3:30 pm day of study visit

Study Arms (6)

Rest, Fed Exercise, Fasted Exercise

EXPERIMENTAL

At Study Visit 2, participants will eat breakfast and rest (abstain from exercise). At Study Visit 3, participants will eat breakfast and exercise. At Study Visit 4, participants will abstain from breakfast and will engage in exercise.

Behavioral: RestBehavioral: Fed ExerciseBehavioral: Fasted Exercise

Rest, Fasted Exercise, Fed Exercise

EXPERIMENTAL

At Study Visit 2, participants will eat breakfast and rest (abstain from exercise). At Study Visit 3, participants will abstain from breakfast and will engage in exercise. At Study Visit 4, participants will eat breakfast and exercise.

Behavioral: RestBehavioral: Fed ExerciseBehavioral: Fasted Exercise

Fed Exercise, Rest, Fasted Exercise

EXPERIMENTAL

At Study Visit 2, participants will eat breakfast and exercise. At Study Visit 3, participants will eat breakfast and rest (abstain from exercise). At Study Visit 4, participants will abstain from breakfast and will engage in exercise.

Behavioral: RestBehavioral: Fed ExerciseBehavioral: Fasted Exercise

Fed Exercise, Fasted Exercise, Rest

EXPERIMENTAL

At Study Visit 2, participants will eat breakfast and exercise. At Study Visit 3, participants will abstain from breakfast and will engage in exercise. At Study Visit 4, participants will eat breakfast and rest (abstain from exercise).

Behavioral: RestBehavioral: Fed ExerciseBehavioral: Fasted Exercise

Fasted Exercise, Fed Exercise, Rest

EXPERIMENTAL

At Study Visit 2, participants will abstain from breakfast and will engage in exercise. At Study Visit 3, participants will eat breakfast and exercise. At Study Visit 4, participants will eat breakfast and rest (abstain from exercise)

Behavioral: RestBehavioral: Fed ExerciseBehavioral: Fasted Exercise

Fasted Exercise, Rest, Fed Exercise

EXPERIMENTAL

At Study Visit 2, participants will abstain from breakfast and will engage in exercise. At Study Visit 3, participants will eat breakfast and rest (abstain from exercise). At Study Visit 4, participants will eat breakfast and exercise.

Behavioral: RestBehavioral: Fed ExerciseBehavioral: Fasted Exercise

Interventions

RestBEHAVIORAL

Participants will eat breakfast but abstain from exercise

Fasted Exercise, Fed Exercise, RestFasted Exercise, Rest, Fed ExerciseFed Exercise, Fasted Exercise, RestFed Exercise, Rest, Fasted ExerciseRest, Fasted Exercise, Fed ExerciseRest, Fed Exercise, Fasted Exercise
Fed ExerciseBEHAVIORAL

Participants will eat breakfast and engage in 30 minutes of physical activity at 75% of their personal V02max.

Fasted Exercise, Fed Exercise, RestFasted Exercise, Rest, Fed ExerciseFed Exercise, Fasted Exercise, RestFed Exercise, Rest, Fasted ExerciseRest, Fasted Exercise, Fed ExerciseRest, Fed Exercise, Fasted Exercise
Fasted ExerciseBEHAVIORAL

Participants will engage in 30 minutes of physical activity at their personal 75% V02max after abstaining from breakfast.

Fasted Exercise, Fed Exercise, RestFasted Exercise, Rest, Fed ExerciseFed Exercise, Fasted Exercise, RestFed Exercise, Rest, Fasted ExerciseRest, Fasted Exercise, Fed ExerciseRest, Fed Exercise, Fasted Exercise

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Engage in loss of control eating at least 12 times in the last three months
  • Clinically significant eating disorder-related impairment (CIA \> 15)
  • Minimum VO2max of 50th percentile for age and sex assigned at birth
  • Be willing to eat study-provided foods
  • Likes chocolate (at least 6/10 on 10 point scale)

You may not qualify if:

  • BMI \< 18.5 kgm/2
  • Medical conditions that affect appetite or weight (e.g., diabetes mellitus, thyroid disease)
  • Recent pregnancy or breastfeeding (prior 6 months)
  • Relevant food allergies (e.g., wheat, chocolate)
  • Specific phobia, blood-injection-injury type
  • Medical condition that precludes safe participation in exercise (e.g., stress fracture)
  • Medications that acutely affect appetite (e.g., GLP-1 agonists; psychiatric medications allowed)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ohio University

Athens, Ohio, 45701, United States

Location

MeSH Terms

Conditions

Feeding and Eating DisordersBinge-Eating DisorderBulimia NervosaMotor Activity

Interventions

RE1-silencing transcription factor

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 12, 2024

First Posted

September 19, 2024

Study Start

August 30, 2024

Primary Completion

April 21, 2026

Study Completion

April 21, 2026

Last Updated

April 30, 2026

Record last verified: 2026-04

Locations